Catalysis and function of the p38 alpha.MK2a signaling complex
- PMID: 15287722
- DOI: 10.1021/bi049508v
Catalysis and function of the p38 alpha.MK2a signaling complex
Abstract
The p38 mitogen-activated protein kinase (p38) pathway is required for the production of proinflammatory cytokines (TNFalpha and IL-1) that mediate the chronic inflammatory phases of several autoimmune diseases. Potent p38 inhibitors, such as the slow tight-binding inhibitor BIRB 796, have recently been reported to block the production of TNFalpha and IL-1beta. Here we analyze downstream signaling complexes and molecular mechanisms, to provide new insight into the function of p38 signaling complexes and the development of novel inhibitors of the p38 pathway. Catalysis, signaling functions, and molecular interactions involving p38alpha and one of its downstream signaling partners, mitogen-activated protein kinase-activated protein kinase 2 (MK2), have been explored by steady-state kinetics, surface plasmon resonance, isothermal calorimetry, and stopped-flow fluorescence. Functional 1/1 signaling complexes (Kd = 1-100 nM) composed of activated and nonactivated forms of p38alpha and a splice variant of MK2 (MK2a) were characterized. Catalysis of MK2a phosphorylation and activation by p38alpha was observed to be efficient under conditions where substrate is saturating (kcat(app) = 0.05-0.3 s(-1)) and nonsaturating (kcat(app)/KM(app) = 1-3 x 10(6) M(-1) s(-1)). Specific interactions between the carboxy-terminal residues of MK2a (370-400) and p38alpha precipitate formation of a high-affinity complex (Kd = 20 nM); the p38alpha-dependent MK2a phosphorylation reaction was inhibited by the 30-amino acid docking domain peptide of MK2a (IC50 = 60 nM). The results indicate that the 30-amino acid docking domain peptide of MK2a is required for the formation of a tight, functional p38alpha.MK2a complex, and that perturbation of the tight-docking interaction between these signaling partners prevents the phosphorylation of MK2a. The thermodynamic and steady-state kinetic characterization of the p38alpha.MK2a signaling complex has led to a clear understanding of complex formation, catalysis, and function on the molecular level.
Similar articles
-
Discovery and characterization of a substrate selective p38alpha inhibitor.Biochemistry. 2004 Sep 21;43(37):11658-71. doi: 10.1021/bi0495073. Biochemistry. 2004. PMID: 15362850
-
p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression.Biochem Biophys Res Commun. 2005 Nov 18;337(2):415-21. doi: 10.1016/j.bbrc.2005.09.063. Epub 2005 Sep 20. Biochem Biophys Res Commun. 2005. PMID: 16198317
-
Mitogen-activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiation.Glia. 2010 Aug 15;58(11):1384-93. doi: 10.1002/glia.21014. Glia. 2010. PMID: 20607863
-
p38 MAP kinase inhibitors: many are made, but few are chosen.Curr Opin Drug Discov Devel. 2005 Jul;8(4):421-30. Curr Opin Drug Discov Devel. 2005. PMID: 16022178 Review.
-
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease.Curr Opin Pharmacol. 2004 Aug;4(4):372-7. doi: 10.1016/j.coph.2004.03.009. Curr Opin Pharmacol. 2004. PMID: 15251131 Review.
Cited by
-
Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.PLoS One. 2015 May 6;10(5):e0125387. doi: 10.1371/journal.pone.0125387. eCollection 2015. PLoS One. 2015. PMID: 25946081 Free PMC article.
-
MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells.EMBO J. 2009 May 20;28(10):1392-406. doi: 10.1038/emboj.2009.100. Epub 2009 Apr 16. EMBO J. 2009. PMID: 19369945 Free PMC article.
-
MK2 degradation as a sensor of signal intensity that controls stress-induced cell fate.Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2024562118. doi: 10.1073/pnas.2024562118. Proc Natl Acad Sci U S A. 2021. PMID: 34272277 Free PMC article.
-
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials.J Med Chem. 2016 Apr 28;59(8):3609-34. doi: 10.1021/acs.jmedchem.5b01457. Epub 2015 Nov 9. J Med Chem. 2016. PMID: 26502061 Free PMC article. Review.
-
Early zebrafish development: it's in the maternal genes.Curr Opin Genet Dev. 2009 Aug;19(4):396-403. doi: 10.1016/j.gde.2009.06.002. Epub 2009 Jul 14. Curr Opin Genet Dev. 2009. PMID: 19608405 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases